Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Arthritis & Rheumatology (Hoboken, N.J.)|November 26, 2022
Syk Activation in Circulating and Tissue Innate Immune Cells in Antineutrophil Cytoplasmic Antibody-Associated VasculitisMaria Prendecki, Kavita Gulati, Noelle Pisacano, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 29, 2025
Association between COVID-19 vaccine immunogenicity and protection against infection and severe disease in clinically vulnerable patient populations: a systematic review and meta-analysis of observational studiesMaria Danysz, Rute Cardoso De Aguiar, Hema Pindolia, et al.
Trials|April 13, 2021
Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trialNikhil Vergis, Rachel Phillips, Victoria Cornelius, et al.
Transplantation|November 16, 2020
Mortality Rates in Transplant Recipients and Transplantation Candidates in a High-prevalence COVID-19 EnvironmentNizam Mamode, Zubir Ahmed, Gareth Jones, et al.
Transplantation|June 18, 2024
Banff 2022 Kidney Commentary: Reflections and Future DirectionsMarion Rabant, Benjamin A Adam, Olivier Aubert, et al.
Nature Medicine|July 6, 2023
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive diseaseEleanor Barnes, Carl S Goodyear, Michelle Willicombe, et al.
Clinical Kidney Journal|February 12, 2025
Sharing regional capacity in deceased donor kidney transplantation: experience from a regional collaborative in a metropolitan areaTamara Wanigasekera, Isaac Kim, Hannah Maple, et al.
Nature Communications|December 15, 2022
Multi-omics identify falling LRRC15 as a COVID-19 severity marker and persistent pro-thrombotic signals in convalescenceJack S Gisby, Norzawani B Buang, Artemis Papadaki, et al.
The Lancet. Rheumatology|May 11, 2024
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trialCarl S Goodyear, Amit Patel, Eleanor Barnes, et al.
BMJ Open|January 31, 2023
Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study, Edward Pk Parker, John Tazare, et al.
Pageof 11